相关实验视频

Updated: Jun 7, 2025

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

化疗诱导的CD47表达在上皮卵巢癌中的增加

Ling Zhao^1,2, Xueqin Wang², Haining Liu²

¹Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

|November 15, 2024

概括

化疗增加了CD47表达在上皮卵巢癌 (EOC),可能阻碍免疫反应. 这一发现表明,为了改善EOC治疗结果,与化疗一起优化CD47向疗法.

科学领域:

妇科瘤学妇科瘤学
免疫学免疫学免疫学
癌症治疗方法癌症治疗方法

背景情况:

表皮卵巢癌 (EOC) 是一种具有有限治疗选择的致命恶性瘤.
CD47充当免疫检查点,促进瘤免疫逃避,是临床试验的目标.
了解化疗对CD47的影响对于确定EOC中CD47向治疗的时间至关重要.

研究的目的:

评估化疗对EOC中CD47表达的影响.
确定在卵巢癌治疗中将CD47向治疗与化疗相结合的最佳时间.

主要方法:

在新辅助化疗 (NACT) 之前和之后对EOC组织样本进行免疫组织化学 (IHC).
对临床和生存数据的回顾性分析.
通过RT-qPCR和流细胞测量来评估CD47mRNA和卵巢癌细胞系中卵巢癌细胞系中的蛋白质表达.

主要成果:

在NACT前的EOC病例中,CD47在80.8%的EOC病例中表达,与预后无关.
化疗在匹配的EOC组织中显著增加了CD47表达 (P=0.006).
西斯普拉丁治疗在卵巢癌细胞中增加了CD47mRNA和细胞表面蛋白质水平 (P<0.001).

结论:

CD47在EOC中表达很高,NACT上调其表达,可能促进免疫逃避.
基于的化疗可能会增加CD47mRNA和卵巢癌中的蛋白质表达.
这些发现支持对ECC的CD47向和化疗联合策略的进一步调查.

关键词:

CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 卵巢上皮癌 (EOC) 是一种卵巢癌.化学疗法化疗化疗免疫疗法免疫疗法有针对性的治疗.

更多相关视频

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...